Expert opinion recommendations for external quality assessment for liquid biopsy testing from the European liquid biopsy society CTDNA workshop

Résumé fourni par la source

Introduction: External Quality Assurance (EQA) / Proficiency testing (PT) enables independent measurement of the standard of laboratory testing and reporting. It also provides education to aid improvements of services offered by molecular testing laboratories through sharing of good practice. The increasing number of clinically relevant somatic genetic events that can be detected in plasma-derived circulating cell-free DNA (cfDNA) demonstrates the need for EQA to continually review the scope of its assessments and include key elements for circulating tumor DNA (ctDNA) testing as evidence of their clinical utility evolves.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.